Ocular Surface Preparation for Refractive Cataract Surgery

This is editorially independent content
6 min read

Sit down with Niraj Desai, MD, to review how ophthalmologists can optimize the ocular surface prior to refractive cataract surgery.

On this episode of Interventional Mindset, Niraj Desai, MD, reviews conditions that are frequently missed during refractive cataract evaluations which require ocular surface optimization prior to surgery.
Dr. Desai is a cataract, cornea, and laser assisted in situ keratomileusis (LASIK) surgeon who practices at Milan Eye Center in Atlanta, Georgia.

Interventional Mindset is an educational series that gives eye physicians the needed knowledge, edge, and confidence in mastering new technology to grow their practices and provide the highest level of patient care. Our focus is to reduce frustrations associated with adopting new technology by building confidence in your skills to drive transformation.

Browse through our videos on a variety of topics within cataract and refractive surgery, glaucoma, and ocular surface disease to learn practical insights into adopting a variety of new surgical techniques and technology.

Conditions to assess patients for during cataract evaluations

Cataract surgery has evolved into a refractive procedure,1 Dr. Desai noted, and as such, it is of utmost importance to ensure that the ocular surface is optimized to limit errors in pre-operative diagnostic testing and for the success of advanced technology intraocular lens (AT-IOL) implants.

Anterior basement membrane dystrophy (ABMD)

One of the more common diseases that Dr. Desai encounters during cataract evaluations is anterior basement membrane dystrophy (ABMD). He explained that it can show up as central or paracentral irregular astigmatism on topography, but if it is significant enough, it may impact the overall topography and cause an increased higher-order aberration profile.2
Dr. Desai’s treatment approach for ABMD is to perform corneal debridement and supplant this with an amniotic membrane graft (if needed) prior to cataract surgery. He added that he usually treats one eye at a time, typically 1 month apart, and once both eyes are treated, he waits 2 to 3 months before performing cataract surgery. At the time of surgery, he performs a simple debridement and then places an amniotic membrane.
He added that while not all ABMD needs to be treated, more often than not, it can interfere with the quality of vision if patients want diffractive or toric IOLs.3
Carousel 1: Slit lamp images of anterior basement membrane dystrophy.
Carousel 1: Images courtesy of Niraj Desai, MD.

Salzmann nodules

Salzmann nodules can be missed during evaluations because they are often peripheral and can be confused for scarring, noted Dr. Desai.3 He added that patients are often asymptomatic and have been seen by an eyecare practitioner for years without having been informed of the nodules.
Consequently, part of the challenge in managing these patients is informing them that they have a condition that requires treatment prior to cataract surgery, explaining the condition to them, and outlining what is required to get rid of the nodules. To treat Salzmann nodules, Dr. Desai performs a superficial keratectomy and post-operatively uses an amniotic membrane concurrently with mitomycin C in most patients.4
In his surgical experience, this protocol results in good outcomes for the patient, sometimes dramatically improving the corneal surface and astigmatism profile to such a degree that the patient no longer feels they need cataract surgery.
Carousel 2: Slit lamp photographs of Salzmann nodules.
Carousel 2: Images courtesy of Niraj Desai, MD.

To learn how surgeons can effectively manage patient treatment expectations through roadmapping, watch the full video!

Dry eye

Dry eye disease (DED) is also often looked over during cataract evaluations, and as a complex and multifactorial condition, it is critical to identify the root cause, such as evaporative or aqueous deficient DED.5
During cataract evaluations, Dr. Desai likes to review the patient’s medication list and discuss any habits that may contribute to dry eye to identify easy ways to improve the patient’s ocular surface health. For example, patients may benefit from a simple swap, such as switching from daily oral antihistamines to a nasal steroid, to help the patient regain moisture levels.
Beyond medication and ergonomic (ex., adding a humidifier) adjustments, DED patients often require further therapies, such as punctal plugs and interventional meibomian gland treatments, to manage their dry eye. Dr. Desai noted that one of the applications for newer-generation amniotic membranes, such as CAM360 AmnioGraft (BioTissue, Inc.), is for dry eye, particularly when seeking to improve the ocular surface.7
Carousel 3: Slit lamp images of corneal staining caused by dry eye disease.
Carousel 3: Images courtesy of Niraj Desai, MD.

The case for amniotic membrane grafting

In Dr. Desai’s opinion, amniotic membrane grafts are a great adjunctive tool for cataract surgeons to optimize the ocular surface. Cryopreserved amniotic membrane (CAM) has demonstrated efficacy in sustained ocular surface improvement by (1) reducing the inflammatory load on the ocular surface and (2) promoting corneal nerve regeneration with several applications over time.8
The official indications for CAM include:9
  • DED
  • Superficial punctate keratitis (SPK)
  • Ocular surface optimization
  • Glaucoma-medication-induced dry eye
  • Stage 1 neurotrophic keratitis (NK)
He has found CAM to be particularly useful for treating stage 1 NK, though it can be challenging to identify NK patients during earlier stages, meaning it is of utmost importance to know how to assess patients for NK, make the diagnosis early, and utilize effective and appropriate therapies to deliver optimal visual outcomes.

Conclusion

Cataract surgery can deliver outstanding visual outcomes; however, in cases where patients are unhappy with the result, Dr. Desai has found that this is often connected to the patient’s pre- and post-operative ocular surface health rather than the IOL itself.
Consequently, it is crucial to address ocular surface and corneal disease appropriately prior to surgery, especially if the patient is requesting AT-IOLs that work best with a visual system that can transmit light uninterrupted.
  1. Chen M. Refractive Cataract Surgery - What We Were, What We Are, And What We Will Be: A Personal Experience and Perspective. Taiwan J Ophthalmol. 2019;9(1):1-3. doi:10.4103/tjo.tjo_133_18
  2. Stodola E. Identifying EBMD: Looking for Blurry Vision and Other Signs. EyeWorld. December 2021. Accessed October 18, 2024. https://www.eyeworld.org/2021/identifying-ebmd/.
  3. Bellucci C, Mora P, Tedesco SA, et al. Acuity and Quality of Vision in Eyes with Epithelial Basement Membrane Dystrophy After Regular Pseudophakia. J Clin Med. 2021;12(3):1099. doi: 10.3390/jcm12031099
  4. Brown AC, Nataneli N. Salzmanns Nodular Corneal Degeneration. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2023. Accessed October 18, 2024. https://www.ncbi.nlm.nih.gov/books/NBK560684/.
  5. Kim T, Meyer JJ. Superficial Keratectomy for Salzmann’s Nodular Degeneration: Techniques and Pointers. American Academy of Ophthalmology. October 18, 2013. Accessed October 18, 2024. https://www.aao.org/education/current-insight/superficial-keratectomy-salzmanns-nodular-degenera.
  6. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75-92. doi: 10.1016/s1542-0124(12)70081-2.
  7. Delaney-Gesing A. BioTissue Launches CAM360 AmnioGraft Regenerative Therapy. Glance by Eyes On Eyecare. Published Jun 4, 2024. Accessed October 21, 2024. https://glance.eyesoneyecare.com/stories/2024-06-04/biotissue-launches-cam360-amniograft-regenerative-therapy/.
  8. McDonald MB, Sheha H, Tighe S, et al. Treatment Outcomes in the Dry Eye Amniotic Membrane (DREAM) Study. Clin Ophthalmol. 2018;2018(12):677-681. doi: https://doi.org/10.2147/OPTH.S162203
  9. CAM360 AmnioGraft. BioTissue. Accessed October 21, 2024. https://biotissue.com/products/ocular/cam360-amniograft/.
Niraj Desai, MD
About Niraj Desai, MD

Niraj Desai, MD, is a board-certified ophthalmologist based in Atlanta, Georgia, who specializes in cataract surgery, LASIK, and corneal transplant surgery.

After completing his undergraduate studies in 2 years, Dr. Desai began his medical career at the Medical College of Georgia. Dr. Desai was selected to be a part of a surgical volunteer program at the famed Christian Medical College in Vellore, India, during his second year of medical school.

After graduating in the top 10% of his class, Dr. Desai completed an internal medicine internship at the University of Hawaii. His ophthalmology residency took him to the University of Texas at San Antonio. During residency, Dr. Desai conducted studies with the United States Air Force in the field of laser surgery. His findings from these studies have been presented at national meetings. Dr. Desai was also recognized with the distinction of having performed the highest number of surgeries in his residency class.

A developing interest in cornea and refractive surgery brought Dr. Desai to Southern California, where he was chosen to complete a prestigious fellowship in the Department of Ophthalmology at the University of California, Irvine. During his time at UC Irvine, Dr. Desai gained expertise in the realm of complex cataract and anterior segment surgery as well as corneal disease and refractive laser surgery.

Niraj Desai, MD
How would you rate the quality of this content?
💙 Interventional Mindset Sponsors
Dompé
Glaukos
Tarsus Pharmaceuticals
Miebo
Sight Sciences
Amgen